We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17.7B
AUM Growth
+$1.64B
Cap. Flow
+$829M
Cap. Flow %
4.68%
Top 10 Hldgs %
32.88%
Holding
1,375
New
60
Increased
737
Reduced
285
Closed
62

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$115M
2
ESS icon
Essex Property Trust
ESS
+$110M
3
AAPL icon
Apple
AAPL
+$103M
4
TSLA icon
Tesla
TSLA
+$101M
5
MSFT icon
Microsoft
MSFT
+$97.5M

Sector Composition

Rank Sector Weight
1 Real Estate 45.88%
2 Technology 16.72%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNSA icon
1226
Kiniksa Pharmaceuticals
KNSA
$6.24B
$3K ﹤0.01%
139
MGNX icon
1227
MacroGenics
MGNX
$236M
$3K ﹤0.01%
209
OABI icon
1228
OmniAb
OABI
$284M
$3K ﹤0.01%
475
OLMA icon
1229
Olema Pharmaceuticals
OLMA
$988M
$3K ﹤0.01%
224
ORIC icon
1230
Oric Pharmaceuticals
ORIC
$1.19B
$3K ﹤0.01%
+249
New +$2.96K
PLRX icon
1231
Pliant Therapeutics
PLRX
$66.3M
$3K ﹤0.01%
196
PRME icon
1232
Prime Medicine
PRME
$545M
$3K ﹤0.01%
398
RGNX icon
1233
Regenxbio
RGNX
$624M
$3K ﹤0.01%
146
SLRN
1234
DELISTED
ACELYRIN
SLRN
$3K ﹤0.01%
398
SVRA icon
1235
Savara
SVRA
$1.08B
$3K ﹤0.01%
553
TNGX icon
1236
Tango Therapeutics
TNGX
$4.23B
$3K ﹤0.01%
355
YMAB
1237
DELISTED
Y-mAbs Therapeutics
YMAB
$3K ﹤0.01%
+162
New +$2.18K
ZLAB icon
1238
Zai Lab
ZLAB
$2.07B
$3K ﹤0.01%
193
ZNTL icon
1239
Zentalis Pharmaceuticals
ZNTL
$332M
$3K ﹤0.01%
212
ZYME icon
1240
Zymeworks
ZYME
$1.63B
$3K ﹤0.01%
286
ADPT icon
1241
Adaptive Biotechnologies
ADPT
$3.54B
$2K ﹤0.01%
530
ALEC icon
1242
Alector
ALEC
$170M
$2K ﹤0.01%
277
ALXO icon
1243
ALX Oncology
ALXO
$262M
$2K ﹤0.01%
138
ANAB icon
1244
AnaptysBio
ANAB
$1.55B
$2K ﹤0.01%
105
ARQT icon
1245
Arcutis Biotherapeutics
ARQT
$3.51B
$2K ﹤0.01%
245
AVXL icon
1246
Anavex Life Sciences
AVXL
$233M
$2K ﹤0.01%
314
BMEA icon
1247
Biomea Fusion
BMEA
$90.4M
$2K ﹤0.01%
109
CGEM icon
1248
Cullinan Oncology
CGEM
$1.05B
$2K ﹤0.01%
127
CNTA
1249
DELISTED
Centessa Pharmaceuticals
CNTA
$2K ﹤0.01%
211
COGT icon
1250
Cogent Biosciences
COGT
$6.82B
$2K ﹤0.01%
281

Similar funds

Daiwa Securities Group's Q1 2024 Portfolio in Review

As of Q1 2024, Daiwa Securities Group held 1,375 positions worth $17.7B, up 10% from $16.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group deployed $829M of net new capital in Q1 2024, opening 60 new positions and adding to 737 existing holdings. Its largest new stake was American Healthcare REIT: 241,461 shares worth $3.56M.

By sector, the portfolio is most concentrated in Real Estate at 46% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Mid-America Apartment Communities, an estimated $122M trimmed.

  • Daiwa Securities Group's largest Q1 2024 buy was American Healthcare REIT: 241,461 shares worth $3.56M.
  • Daiwa Securities Group added most to Equinix in Q1 2024, an estimated $115M increase.
  • Daiwa Securities Group's biggest Q1 2024 reduction was Mid-America Apartment Communities, cutting an estimated $122M.
  • Daiwa Securities Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $70.5M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $17.7B portfolio in Q1 2024.
  • Daiwa Securities Group opened 60 new positions and closed 62 in Q1 2024.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $17.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.